Stock RGLS REGULUS THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Regulus Therapeutics Inc.

Equities

RGLS

US75915K3095

Market Closed - Nasdaq
Other stock markets
 01:30:00 14/05/2024 am IST 		5-day change 1st Jan Change
2.09 USD -5.43% Intraday chart for Regulus Therapeutics Inc. -13.99% +63.28%
09/05 Regulus Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
06/05 Regulus Therapeutics Advances to Cohort 4 of Phase 1B Multiple-Ascending Dose Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease CI
a5de5fd7be59631da.kE9DIA3Pf7m_BLq6HdKb5RGkdRBGbad9MDogYkVCync.1SYvF3WGEozlTuvWZYL3n3jQPigkXZ8HCEsQBwEgowDJCRlXdaAZ_OVpgg~26648ace0808300811603a4bc2510d01
  1. Stock Market
  2. Equities
  3. RGLS Stock
  4. Charts Regulus Therapeutics Inc.
  5. News Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW